SHAWNA FROST: Open Payments
NPI 1396010799 · FARMINGTON, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$486 in 29 payments from 9 companies in 2025. Trend: 2023 $870 · 2024 $461 · 2025 $486
Food & beverage: $486
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $222 |
| Insulet Corporation | 3 | $83 |
| Merck Sharp & Dohme LLC | 2 | $37 |
| PFIZER INC. | 2 | $32 |
| Novo Nordisk Inc | 1 | $24 |
| Otsuka America Pharmaceutical, Inc. | 1 | $23 |
| Xeris Pharmaceuticals, Inc. | 1 | $23 |
| Gilead Sciences, Inc. | 1 | $22 |
| Lilly USA, LLC | 1 | $19 |
Products named: MAVYRET, Omnipod, QULIPTA, PIFELTRO, NURTEC ODT, Wegovy, REXULTI, GVOKE HYPOPEN.
Industry payments across NM — which companies pay providers there.
